Patent · US Active

Scoring methods for anti-PD therapy eligibility and compositions for performing same

US11585817B2 · kind B2 · utility

0Cited by
1References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 28, 2020
Grant dateFeb 21, 2023
Priority date
Expiry dateNov 17, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Aspects of the present disclosure provide methods for determining the eligibility of a subject having a malignancy for treatment with an anti-PD therapeutic agent based on a Combined Positive Score (CPS) for a tumor tissue sample from the subject. Compositions and kits or performing the disclosed methods are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.